The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Type 2 DiabetesDyslipidemia
Interventions
DRUG

Insulin

Insulin is given as a constant infusion( 0,6 mU/kg/min) during the hyperinsulinemia period of the study lasting four and a half hour.

DRUG

insulin

Insulin is given as a constant infusion( 0,6 mU/kg/min) during the hyperinsulinemia period of the study lasting four and a half hour.

OTHER

diet

The subjects ingest a three day isocaloric diet (55 % carbohydrate,30% fat, 15 % protein)prior to the study day.

OTHER

no diet

The subjects will ingest a non-restricted diet prior to the study day.

Trial Locations (1)

8000

Department of Endocrinology MEA, Aarhus Hospital, Aarhus C

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT01564550 - The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism | Biotech Hunter | Biotech Hunter